NCT05653765Active, not recruiting
Prognostic Value of the AMR Measured After PPCI in STEMI Patients
Prognostic Value of the Angio-based Microvascular Resistance Use One Single Angiographic View Measured After Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction Patients
Source: ClinicalTrials.gov · Last updated 17 Mar 2025
Brief summary (registry, in English)
The goal of this observational study is to learn about in STEMI with Primary PCI Patients. The main questions it aims to answer are: * To determine the value of AMR in predicting the long-term clinical prognosis of patients with STEMI after PPCI, and to find the best cut-off value. * Analyze the factors of PPCI affecting AMR and explore the effective measures of PPCI microcirculation protection. Radiographic images of STEMI receiving primary PCI treatment in several chest pain centers in China will be included. The last image of the infarct-related vessel will be used as a target to calculate its AMR. The relationship between AMR and long-term clinical prognosis was analyzed.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 2663 (actual)
- First submitted
- 4 Nov 2022
- Start date
- 20 Dec 2022
- Primary completion date
- 20 Dec 2023
- Lead sponsor
- Henan Institute of Cardiovascular Epidemiology
- Diseases
- Coronary artery disease
- NCT number
- NCT05653765
What you commit to
- Study type: Observational
- Participants enrolled: 2663
- From 20 Dec 2022 to the primary completion date, 20 Dec 2023
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Unable to tolerate dual antiplatelet therapy
Other illness
- Structural heart disease with moderate to severe aortic valve or mitral regurgitation and or stenosis that may affect cardiac function
- Dialysis patients with severe renal insufficiency
- Severe and uncontrollable arrhythmia
Other
- Failed to identify culprit vessels.
- Complicated with dilated cardiomyopathy
- Severe and uncontrollable anemia
- Hyperthyroidism
- TIMI blood flow 0-1 grade after PPCI
Who the study is looking for
- Aged 18 or older
- Type 1 myocardial infarction
- Receive PPCI
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Renji Hospital, School of Medicine, Shanghai Jiao Tong University Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
| Shangqiu First People's Hospital Coordinator of this site? Confirm its status | Shangqiu | China | Unknown status |
| Department of Cardiology, First Affiliated Hospital of Xinxiang Medical University Coordinator of this site? Confirm its status | Xinxiang | China | Unknown status |
| Yongcheng Central Hospital Coordinator of this site? Confirm its status | Yongcheng | China | Unknown status |
| Fuwai Central China Cardiovascular Hospital Coordinator of this site? Confirm its status | Zhengzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.